Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Marta Zarandi"'
Autor:
Renzhi Cai, Tengjiao Cui, Jozsef L. Varga, Luca Szalontay, Marta Zarandi, Gabor Halmos, Andrew V. Schally, Xian Yang Zhang, Ferenc G. Rick, Petra Popovics, Wei Sha, Magdolna Kovacs, Norman L. Block, Miklós Jászberényi
Publikováno v:
Peptides. 89:60-70
The syntheses and biological evaluations of new GHRH analogs of Miami (MIA) series with greatly increased anticancer activity are described. In the design and synthesis of these analogs, the following previous substitutions were conserved: D-Arg2, Ha
Autor:
Joshua M. Hare, Norman L. Block, Marta Zarandi, Luca Szalontay, Ren Zhi Cai, Miklós Jászberényi, Petra Popovics, Rosemeire M. Kanashiro-Takeuchi, Andrew V. Schally, Ferenc G. Rick, Lauro M Takeuchi, Irving Vidaurre
Publikováno v:
Oncotarget
// Rosemeire M. Kanashiro-Takeuchi 1, 2, * , Luca Szalontay 3, * , Andrew V. Schally 1, 3, 4, 5, 6 , Lauro M. Takeuchi 1 , Petra Popovics 3, 7, 8 , Miklos Jaszberenyi 3, 4 , Irving Vidaurre 3 , Marta Zarandi 3 , Ren-Zhi Cai 3, 4 , Norman L. Block 1,
Publikováno v:
Peptides. 62:59-66
Peptide analogs of urocortin 3[36–38] (Ucn 3[36–38]), obtained with deletion or replacement of amino acids of the original human urocortin 3 sequence, were designed, synthesized, and tested in vivo for treatment of depression. Based on the result
Autor:
Marta Zarandi, Joshua M. Hare, Rosemeire M. Kanashiro-Takeuchi, Renzhi Cai, Gabor Halmos, Wei Sha, Magdolna Kovacs, Petra Popovics, Ferenc G. Rick, Jinlin He, Tengjiao Cui, Luca Szalontay, Miklós Jászberényi, Norman L. Block, Andrew V. Schally
Publikováno v:
Peptides. 52:104-112
In view of the recent findings of stimulatory effects of GHRH analogs, JI-34, JI-36 and JI-38, on cardiomyocytes, pancreatic islets and wound healing, three series of new analogs of GHRH(1-29) have been synthesized and evaluated biologically in an en
Autor:
Miklós Jászberényi, Irving Vidaurre, Marta Zarandi, Arumugam R. Jayakumar, Norman L. Block, Andrew V. Schally, Ren Zhi Cai, Luca Szalontay, Ferenc G. Rick
Publikováno v:
Targeted Oncology. 8:281-290
Five-year survival of patients afflicted with glioblastoma multiforme (GBM) is rare, making this cancer one of the most feared malignancies. Previously, we reported that growth hormone-releasing hormone (GHRH) is a potent growth factor in cancers. Th
Autor:
Andrew V. Schally, Renzhi Cai, Wei Sha, Luis Rodriguez-Menocal, Norman L. Block, Tengjiao Cui, Ailin Vila Granda, Marta Zarandi, Roberto Perez, Joaquin J. Jimenez, Evangelos V. Badiavas
Publikováno v:
Oncotarget
// Tengjiao Cui 1,2,7 , Joaquin J. Jimenez 4,5 , Norman L. Block 3 , Evangelos V. Badiavas 4,8 , Luis Rodriguez-Menocal 4,8 , Ailin Vila Granda 4 , Renzhi Cai 1,2,7 , Wei Sha 1,2,8 , Marta Zarandi 1,2 , Roberto Perez 1,2 and Andrew V. Schally 1,2,3,6
Autor:
Marta Zarandi, Ren Zhi Cai, Andrew V. Schally, Miklós Jászberényi, Luca Szalontay, Norman L. Block, Ferenc G. Rick
Publikováno v:
Aging (Albany NY)
Alzheimer's disease is the most frequent debilitating disorder of the central nervous system. Neuroendocrine mechanisms appear to play an important role in this insidiously developing disease. In the present study, the effects of a recently developed
Autor:
May Abdel-Wahab, Marta Zarandi, You-Fang Shi, Teresita Reiner, Omar Mahmoud, Arnold M. Markoe, Andrew V. Schally, Norman L. Block, Merce Jorda, Robert Duncan, Ferenc G. Rick, Luca Szalontay
Publikováno v:
Journal of Radiation Oncology. 1:389-396
Purpose This study seeks to determine if growth hormone-releasing hormone (GHRH) antagonist, JMR-132, increases survival when given before whole body radiation.
Autor:
Filippo de Braud, Gianfranco Delle Fave, Norman L. Block, S.L. Miller, Marta Zarandi, Gabriele Capurso, Daniel J. Spergel, Luigi Dogliotti, Davide Campana, Aldo Scarpa, Vesna Starcevic, Luca Szalontay, Ralf Gilsbach, Mirjana Sumarac-Dumanovic, Mehrdad Nadji, Ignacio Camacho-Arroyo, Dragan Micic, D.W. Walker, Kristina Janjetovic, Druck Reinhardt Druck Basel, Paola Tomassetti, D.M. Yates, Mika Scheinin, J.J. Hirst, Maja Misirkic, Karla Hernández-Fonseca, Francesco Panzuto, Vladimir Trajkovic, Massimo Falconi, Andrew V. Schally, Giovanni Di Meglio, Ronald J. Benveniste, H.K. Palliser, Maria Pia Brizzi, Lutz Hein, Eriika Savontaus, Saku Ruohonen, E.M. Wallace, Ljubica Vucicevic, Magdolna Kovacs, Darko Stevanovic, Lourdes Massieu, Bailey A. Kermath, Suvi T. Ruohonen, Selene García de la Cadena, Xiao-Bing Zhang, Satz Mengensatzproduktion, Letizia Boninsegna, Nicola Fazio, Andrea C. Gore, Carolina Guzmán, Irving Vidaurre, Francesca Nori
Publikováno v:
Neuroendocrinology. 96:89-96
Autor:
Anton Stangelberger, Marta Zarandi, Jozsef L. Varga, Gabor Halmos, Benjamin Baker, Ferenc G. Rick, Andrew V. Schally
Publikováno v:
The Prostate. 72:555-565
BACKGROUND The tumor suppressor gene p53 is implicated in cell cycle control and apoptosis. Antagonists of growth hormone-releasing hormone (GHRH) have been shown to inhibit human experimental prostate cancers. METHODS We investigated the involvement